Epidural Lysis of Adhesions for Failed Back Surgery and Spinal Stenosis
Authors:
- Eugene HsuEHEugene Hsu
- Levan AtanelovLALevan Atanelov
- Anthony R. PlunkettAPAnthony R. Plunkett
- Nu ChaiNCNu Chai
- Yian ChenYCYian Chen
- Steven P. CohenSCSteven P. Cohen
- 1 January 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 118 (1) , 215-224
Abstract
Failed back surgery syndrome (FBSS) is a challenging problem. One treatment advocated to treat FBSS is epidural lysis of adhesions (LOA). The results of studies examining LOA for FBSS have been mixed, but are limited because no study has ever sought to identify factors associated with outcomes. We performed this multicenter, retrospective study in 115 patients who underwent LOA for FBSS (n = 104) or spinal stenosis (n = 11) between 2004 and 2007. Twenty-seven demographic, clinical, and procedural variables were extracted from medical records and correlated with the outcome, defined as ≥50% pain relief lasting ≥1 month. Univariable analysis was performed, followed by multivariable logistic regression. Overall, 48.7% (95% confidence interval [CI], 39.3%–58.1%) of patients experienced a positive outcome. In univariable analysis, those who had a positive outcome were older (mean age 64.1 years; 95% CI, 59.7–68.6 vs 57.2; 95% CI, 53.0–61.4 years; P = 0.02), while higher baseline numerical rating scale pain scores were associated with a negative outcome (mean 6.7 years; 95% CI, 6.0–7.3 vs 7.5; 95% CI, 6.9–8.0; P = 0.07). Use of hyaluronidase did not correlate with outcomes in univariable analysis (odds ratio [OR], 1.2; 95% CI, 0.6–2.5; P = 0.65). In multivariable analysis, age ≥81 years (OR, 7.8; 95% CI, 1.4–53.7), baseline numerical rating scale score ≤9 (OR, 4.4; 95% CI, 1.4-16.3, P = 0.02), and patients on or seeking disability or worker’s compensation (OR, 4.4; 95% CI, 1.1-19.5, P = 0.04) were significantly more likely to experience a positive outcome. Considering our modest success rate, selecting patients for epidural LOA based on demographic and clinical factors may help better select treatment candidates. Procedural factors such as the use of hyaluronidase that increase risks and costs did not improve outcomes, so further research is needed before these become standard practice.Keywords
This publication has 25 references indexed in Scilit:
- Update on the evidence for adjacent segment degeneration and diseaseThe Spine Journal, 2013
- Emerging Trends in Clinical Trial DesignAnesthesia & Analgesia, 2013
- The Role of Adding Hyaluronidase to Fluoroscopically Guided Caudal Steroid and Hypertonic Saline Injection in Patients with Failed Back Surgery Syndrome: A Prospective, Double-Blinded, Randomized StudyPain Practice, 2010
- Adjacent Segment Disease After Instrumented Fusion for Idiopathic ScoliosisJournal of Spinal Disorders & Techniques, 2009
- Peridural scar and its relation to clinical outcome: a randomised study on surgically treated lumbar disc herniation patientsEuropean Spine Journal, 2008
- Percutaneous Lysis of Epidural Adhesions—Evidence for Safety and EfficacyPain Practice, 2008
- The Effect of Opioid Dose and Treatment Duration on the Perception of a Painful Standardized Clinical StimulusRegional Anesthesia & Pain Medicine, 2008
- Predictive factors for 1-year and 5-year outcome for disability in a working population of patients with low back pain treated in primary carePain, 2006
- Neurostimulation for Chronic Neuropathic Back Pain in Failed Back Surgery SyndromeJournal of Pain and Symptom Management, 2006
- GENETICALLY DETERMINED DIFFERENCES IN COCAINE CARDIOTOXICITY ARE ALTERED BY NITRIC OXIDE SYNTHESIS INHIBITIONRegional Anesthesia & Pain Medicine, 1999